• Explore /
  • Poster
  • / Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

Abstract Poster

Authors

Andrea Apolo

Andrea B. Apolo

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Andrea B. Apolo , John Allan Ellerton , Jeffrey R. Infante , Manish Agrawal , Michael S. Gordon , Raid Aljumaily , Carolyn D. Britten , Luc Yves Dirix , Keun-Wook Lee , Matthew H. Taylor , Patrick Schöffski , Ding Wang , Alain Ravaud , Arnold Gelb , Junyuan Xiong , Galit Rosen , Manish R. Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT01772004

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4528)

DOI

10.1200/JCO.2017.35.15_suppl.4528

Abstract #

4528

Poster Bd #

206

Abstract Disclosures

Similar Posters

First Author: Manish R. Patel

First Author: Andrea B. Apolo

First Author: Andrea B. Apolo

First Author: Andrea B. Apolo